Zacks Research Has Positive Outlook for Itron Q4 Earnings

Itron, Inc. (NASDAQ:ITRI) – Equities research analysts at Zacks Research boosted their Q4 2024 earnings per share (EPS) estimates for shares of Itron in a research report issued on Tuesday, November 19th. Zacks Research analyst R. Department now forecasts that the scientific and technical instruments company will post earnings per share of $1.02 for the quarter, up from their prior estimate of $0.92. The consensus estimate for Itron’s current full-year earnings is $5.33 per share. Zacks Research also issued estimates for Itron’s Q3 2025 earnings at $1.19 EPS, Q2 2026 earnings at $1.32 EPS, Q3 2026 earnings at $1.38 EPS and FY2026 earnings at $5.29 EPS.

Several other research firms have also weighed in on ITRI. Piper Sandler boosted their price target on Itron from $110.00 to $119.00 and gave the stock a “neutral” rating in a research report on Friday, November 1st. Robert W. Baird boosted their target price on Itron from $123.00 to $132.00 and gave the stock an “outperform” rating in a report on Friday, November 1st. Roth Mkm boosted their target price on Itron from $125.00 to $130.00 and gave the stock a “buy” rating in a report on Friday, November 1st. Oppenheimer boosted their target price on Itron from $120.00 to $124.00 and gave the stock an “outperform” rating in a report on Friday, November 1st. Finally, TD Cowen boosted their target price on Itron from $125.00 to $136.00 and gave the stock a “buy” rating in a report on Friday, November 1st. Four investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $123.92.

Itron Stock Up 1.9 %

NASDAQ:ITRI opened at $116.25 on Thursday. The firm has a market capitalization of $5.24 billion, a price-to-earnings ratio of 23.91, a price-to-earnings-growth ratio of 0.86 and a beta of 1.46. Itron has a twelve month low of $65.20 and a twelve month high of $124.90. The stock’s 50 day moving average price is $108.87 and its two-hundred day moving average price is $104.86. The company has a quick ratio of 2.83, a current ratio of 3.36 and a debt-to-equity ratio of 0.91.

Itron (NASDAQ:ITRI) last announced its earnings results on Thursday, October 31st. The scientific and technical instruments company reported $1.84 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.13 by $0.71. The business had revenue of $615.46 million for the quarter, compared to analyst estimates of $596.41 million. Itron had a return on equity of 19.03% and a net margin of 9.37%. Itron’s revenue for the quarter was up 9.8% compared to the same quarter last year. During the same quarter last year, the firm earned $0.98 EPS.

Insider Activity

In other Itron news, CEO Thomas Deitrich sold 37,500 shares of the company’s stock in a transaction dated Tuesday, October 1st. The stock was sold at an average price of $104.83, for a total value of $3,931,125.00. Following the completion of the transaction, the chief executive officer now owns 205,276 shares of the company’s stock, valued at $21,519,083.08. This represents a 15.45 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Joan S. Hooper sold 509 shares of the company’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $102.15, for a total value of $51,994.35. Following the completion of the transaction, the chief financial officer now directly owns 72,338 shares of the company’s stock, valued at approximately $7,389,326.70. The trade was a 0.70 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 39,066 shares of company stock worth $4,092,737. 1.45% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Itron

A number of institutional investors and hedge funds have recently bought and sold shares of the company. Hexagon Capital Partners LLC increased its stake in shares of Itron by 85.6% in the second quarter. Hexagon Capital Partners LLC now owns 271 shares of the scientific and technical instruments company’s stock valued at $27,000 after buying an additional 125 shares during the period. Quarry LP increased its stake in shares of Itron by 53.0% in the second quarter. Quarry LP now owns 352 shares of the scientific and technical instruments company’s stock valued at $35,000 after buying an additional 122 shares during the period. Continuum Advisory LLC increased its stake in shares of Itron by 42.1% in the third quarter. Continuum Advisory LLC now owns 344 shares of the scientific and technical instruments company’s stock valued at $40,000 after buying an additional 102 shares during the period. Covestor Ltd increased its stake in shares of Itron by 26.1% in the third quarter. Covestor Ltd now owns 536 shares of the scientific and technical instruments company’s stock valued at $57,000 after buying an additional 111 shares during the period. Finally, GAMMA Investing LLC boosted its position in shares of Itron by 46.6% during the 2nd quarter. GAMMA Investing LLC now owns 720 shares of the scientific and technical instruments company’s stock valued at $71,000 after purchasing an additional 229 shares in the last quarter. Institutional investors and hedge funds own 96.19% of the company’s stock.

About Itron

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.